NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 90 filers reported holding NEOGENOMICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $418,000 | +13.6% | 46,700 | 0.0% | 0.15% | +14.6% |
| Q1 2017 | $368,000 | -8.0% | 46,700 | 0.0% | 0.13% | -6.5% |
| Q4 2016 | $400,000 | -7.4% | 46,700 | -11.0% | 0.14% | -39.0% |
| Q3 2016 | $432,000 | +2.4% | 52,500 | 0.0% | 0.23% | +21.9% |
| Q2 2016 | $422,000 | +19.2% | 52,500 | 0.0% | 0.19% | -1.6% |
| Q1 2016 | $354,000 | -33.5% | 52,500 | -19.2% | 0.19% | -14.4% |
| Q4 2015 | $532,000 | +43.0% | 65,000 | 0.0% | 0.22% | +85.0% |
| Q3 2015 | $372,000 | +4.2% | 65,000 | 0.0% | 0.12% | +9.1% |
| Q2 2015 | $357,000 | +14.4% | 65,000 | 0.0% | 0.11% | +7.8% |
| Q1 2015 | $312,000 | +15.1% | 65,000 | 0.0% | 0.10% | +20.0% |
| Q4 2014 | $271,000 | -27.7% | 65,000 | 0.0% | 0.08% | -34.6% |
| Q3 2014 | $375,000 | – | 65,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |